Capque Technologies launches Part 11 electronic signature tool for clinical trials

Oct. 20, 2026
By AI, Created 10:56 UTC, Oct 20, 2026, AGP -

Capque Technologies has launched CapqueSign, a new electronic signature platform for regulated clinical research, with self-serve pricing and built-in 21 CFR Part 11 controls. The Atlanta-based launch targets sponsors, CROs and site networks that need compliant signatures without enterprise procurement delays.

Why it matters: - CapqueSign aims to make 21 CFR Part 11-compliant electronic signatures easier to adopt for smaller sponsors, CROs and site networks. - The platform bundles core compliance controls into every plan, including multi-factor authentication and full audit trails. - The launch could reduce time and cost for clinical teams that need regulated signing workflows for trial documents.

What happened: - Capque Technologies LLC launched CapqueSign on October 20, 2026. - CapqueSign is an electronic signature platform for clinical trial documents. - ClinFocus Inc., an Atlanta-based clinical research organization, powers the platform. - CapqueSign is the first product on the Capque Connected Intelligence platform. - The platform supports protocols, protocol amendments, site agreements and other trial documents in PDF and Word formats.

The details: - Electronic signatures used in FDA-regulated clinical research must meet 21 CFR Part 11 requirements for signer authentication, signature manifestation, record linkage and secure audit trails. - CapqueSign includes the same core controls on every plan. - Each signer confirms identity with multi-factor authentication before signing. - Every action is recorded in a full audit trail. - Users can export the audit trail in one step for quality review or filing in an electronic trial master file. - Senders can set signing order and deadlines. - Automated email notifications and reminders keep documents moving without manual follow-up. - The Free plan allows three envelopes per month and does not require a credit card. - The Standard plan costs $19.99 per user per month and includes 25 envelopes per user each month, priority support and access to the CapqueSign validation package on request. - The Enterprise plan includes unlimited users and envelopes with custom pricing based on users, volume and sites. - Annual billing includes two months at no charge. - Capque Technologies validated CapqueSign for 21 CFR Part 11. - Standard and Enterprise customers can request the validation package for internal quality assurance review. - Each regulated organization remains responsible for confirming the system fits its intended use under its own procedures and training. - CapqueSign is available now with self-serve registration at CapqueSign. - Enterprise inquiries can be submitted through the contact page on the same site. - Capque Technologies also directs readers to more information about the company. - ClinFocus provides clinical data management, biostatistics, clinical programming and systems integration services. - ClinFocus is a Medidata Rave accredited partner and operates under 21 CFR Part 11, ICH E6(R3) and GxP frameworks. - ClinFocus also operates a Nigeria-based subsidiary, CFGSN.

Between the lines: - The pricing structure suggests Capque Technologies is targeting teams that need regulated e-signatures but cannot justify enterprise software contracts. - Offering validation evidence on request may help quality teams review compliance without waiting on a custom sales process. - Making MFA and audit trails standard across all plans positions compliance features as baseline infrastructure rather than add-ons.

What's next: - Capque Technologies says clinical teams can start on the free plan and move to Standard without a procurement cycle. - Enterprise customers can pursue custom pricing through direct inquiry. - The company is likely to use CapqueSign as the entry point for the broader Capque Connected Intelligence platform.

The bottom line: - CapqueSign enters the market as a low-friction, Part 11-focused signature tool for regulated clinical research, with transparent pricing and compliance controls built in from the start.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Health Report Nigeria

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Report Nigeria

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.